What Works For Anxiety Disorders–Anti-Anxiety Drugs
Short-term use (up to four weeks)
Our rating
Long-term use
Our rating
GAD
GAD
PTSD and ASD
PTSD and ASD
Social Phobia
Social Phobia
Panic Disorder and Agoraphobia
Panic Disorder and Agoraphobia
Specific Phobias
Specific Phobias
OCD
OCD
WHAT ARE THEY?
Anti-anxiety drugs are used mainly for …
Conventional Antipsychotics – Healthcare Professional Sheet text version
FDA ALERT [6/16/2008]: FDA is notifying healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for …
Viibryd Important Risk Information
VIIBRYD® (vilazodone HCI) is a prescription medicine indicated for the treatment of major depressive disorder (MDD) in adults.
IMPORTANT RISK INFORMATION
What is the most important information I should know about VIIBRYD?
VIIBRYD and other …
What Is ZYPREXA® (olanzapine)?
ZYPREXA is a brand name for a prescription medicine that is approved by the FDA for treating the symptoms of schizophrenia, acute mixed or manic episodes of bipolar I disorder and for …
Depakote Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER
Depakote® 250mg and 500mg Tablets
Valproic acid (as valproate semisodium)
Is this leaflet hard to see or read?
Phone 0845 372 7101 for help
▼ This medicine is subject to additional monitoring. This …
Total Number of People Taking Psychiatric Drugs in the United States
The following information is the most accurate and documented data available on psychiatric drug usage. The information is from IMS Health, a company that provides …
Psychotropic Medication Use among Adolescents: United States, 2005–2010
Key findings
Data from the National Health and Nutrition Examination Survey
Approximately 6.0% of U.S. adolescents aged 12–19 reported psychotropic drug use in the past month.
The use of antidepressants (3.2%) …
